CGIX | tickerfilter.com

Fundamental analysis

45%

Profitability 58%

Dept financing 4%

Liquidity 13%

Performance 50%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-22.78%

1 Month

-29.19%

3 Months

64.06%

6 Months

9.24%

1 Year

70.11%

2 Year

-36.00%

Key data

Stock price

$4.61

P/E Ratio

0.00

DAY RANGE

$4.61 - $4.61

EPS

$0.00

52 WEEK RANGE

$2.11 - $17.50

52 WEEK CHANGE

$0.68

MARKET CAP

35.887 M

YIELD

N/A

SHARES OUTSTANDING

7.785 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.00

PUBLIC FLOAT

AVERAGE 10 VOLUME

$1,946,496

AVERAGE 30 VOLUME

$1,112,146

Company detail

CEO: John Roberts
Region: US
Website: http://www.cancergenetics.com
Employees: 0
IPO year: -

Issue type: Common Stock
Market: NASDAQ
Industry: Medical Laboratories
Sector: Health Care and Social Assistance

CGIX - Cancer Genetics Inc.